Answers are grounded in this paper and cite their sources.
The practical pharmacological approaches currently available to palliate the cognitive and functional losses in early Alzheimer's disease (AD) include cholinesterase inhibitors (ChEI), antioxidants (e.g., vitamin E), anti-inflammatory agents, estrogen, seligiline, vasoactive agents, and ginkgo biloba. Reviewing available data on these therapies and using models from medical illnesses such as cancer and hypertension, we highlight the urgent need for evaluating combination therapies in early AD.
No takes yet. Share an insight, caveat, or question.
Doraiswamy et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: